REPL · Replimune Group, Inc. · Analyst Estimates
$12.92
-0.32 (-2.42%)
At close · Sep 11
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“As described in the Company's Annual Report on Form 10-K for the year ended March 31, 2026, substantial doubt existed about the Company's ability to continue as a going concern. The conditions that raised substantial doubt have been subsequently alleviated, as the Company raised approximately $141.0 million in net proceeds from an equity offering in August 2026.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.22B
Shares
94.22M
Analyst Estimates
Compare analyst forecasts for Replimune Group, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1737953
CUSIP
76029N106
13F (30d)
102 filings
102 filers
Visit website
Investor relations